Q Therapeutics, Inc. Appoints Diane Jorkasky, MD, to Board of Directors
3/14/2013 9:39:10 AM
More...
|
Q Therapeutics, Inc. to Present at the 15th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference
1/31/2013 9:28:46 AM
More...
|
Q Therapeutics, Inc.' CFO and Vice President of Corporate Development, Steve Borst, Featured on theStockRadio.com
1/3/2013 8:40:14 AM
More...
|
Q Therapeutics, Inc. to Present at Biotech Showcase™ 2013 to be Held During JP Morgan Healthcare Conference in San Francisco
1/3/2013 8:37:06 AM
More...
|
Q Therapeutics, Inc.' Collaborators at Johns Hopkins University Are Awarded Funding From National Institutes of Health (NIH)
12/27/2012 10:00:00 AM
More...
|
Q Therapeutics, Inc. Issues Formal Update on Key Corporate and Operational Developments
12/20/2012 8:29:18 AM
More...
|
Q Therapeutics, Inc. Announces U.S. and Canadian Patent Awards
11/28/2012 9:25:22 AM
More...
|
Q Therapeutics, Inc. at Johns Hopkins to Study Use of Neural Glial Cells in Treatment of Myelin Disorders
6/1/2010 2:53:41 PM
More...
|
Q Therapeutics, Inc. And Johns Hopkins University Researchers Collaborate on Study of Human Neural Glial Cells in Treatment of ALS
10/21/2008 9:12:50 AM
More...
|
Q Therapeutics, Inc. Collaborates with Johns Hopkins University to Study Use of Neural Cells in Treatment of ALS
6/12/2008 10:23:42 AM
More...
|
|